Article Details
Retrieved on: 2025-04-04 10:15:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In addition, Ustekinumab, an anti-IL-12/23p40 monoclonal antibody; Janus kinase (JAK) inhibitor; and Vedolizumab, monoclonal antibodies targeting α4β7 ...
Article found on: www.nature.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here